Brookdale Sr Lvg Stock
Brookdale Sr Lvg Stock
There is no change in the price for Brookdale Sr Lvg today.
We see a rather positive sentiment for Brookdale Sr Lvg with 9 Buy predictions and 1 Sell predictions.
As a result the target price of 13 € shows a slightly positive potential of 14.04% compared to the current price of 11.4 € for Brookdale Sr Lvg.
Pros and Cons of Brookdale Sr Lvg in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Brookdale Sr Lvg vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Brookdale Sr Lvg | 0.000% | -4.202% | -5.785% | 123.529% | 25.967% | 203.191% | 103.571% |
| Capital Senior Living Corp. | -1.420% | -1.439% | -1.439% | 48.913% | 1.481% | - | - |
| Healthstream Inc. | -0.580% | -4.571% | -5.114% | -40.780% | -14.359% | -32.114% | -8.242% |
| Evolent Health Inc | -0.930% | 2.073% | -24.231% | -77.356% | -42.398% | -93.207% | - |
Comments
Brookdale Senior Living (BKD) is now covered by Stephens. They set an "overweight" rating and a $18.00 price target on the stock.
Show more
Ratings data for BKD provided by MarketBeat
Brookdale Senior Living (NYSE:BKD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Show more
Ratings data for BKD provided by MarketBeat
Brookdale Senior Living (NYSE:BKD) had its price target raised by analysts at Barclays PLC to $18.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BKD provided by MarketBeat